Policy, performance and finance are the issues currently headlining the healthcare agenda and are likely to remain so for the foreseeable future. Drawing on experiences from around the world, this essential collection examines the key strategic issues facing health services and analyzes the policy implications of leading new research. The volume brings together 16 newly-commissioned studies from leading experts in health studies, in particular: policy, economics, health care management and health services research. International in perspective and scope, it draws on empirical evidence from East and West Europe, Canada, New Zealand and the Middle East. Themes covered include: health policy and technology assessment, policy and performance, international policy innovation, and organizational innovation. This ground-breaking collection will prove a valuable guide for policy makers, managers, practitioners, researchers and students.

This title was first published in 2001. Enhancing the quality of health services remains a key challenge for all health systems, whatever their stage of development. This collection of leading-edge research from Europe and America explores both quantitative and qualitative approaches to identifying and remedying deficiencies in health care.

The title was first published in 2001: The papers in this volume, selected from nearly 100 submissions to the Fourth International Conference on Strategic Issues in Health Care Management, reflect the work taking place in health economics. The first five chapters in the collection examine the role of economics within clinical guidelines and suggest methods of improving the quality of economic evaluation which is now at the centre of decision-making in the NHS. The second section of the book is comprised of two papers on inequalities and access. The third part contains four papers, two of which cover reviews and tackle some theoretical issues regarding demand, and two are applied case studies. The fourth section assesses performance, and the final four papers review health reforms in a number of countries including the UK, Canada, France and Turkey.

Controlling costs in health care is rarely something that can be tackled in isolation. Cost control invariably interacts with issues of quality and health care access. Thus, this diverse collection of papers is concerned not just with costs but more importantly with value. Both macro and micro concerns are covered. At the macro level, health care reforms (and especially the 'marketisation' of health care systems) receive some attention. Papers explore how policy prescriptions get translated and modified during implementation, and assess how these prescriptions impact on both the incentive context and subsequent patterns of service delivery. Resource allocation within bureaucratic health systems continues to pose problems and these too are analysed with new solutions being proposed. At the micro level, a number of contributors wrestle with the difficulties of carrying out the economic evaluation of new drugs and technologies. In each case, the wider theoretical and practical implications of balancing costs and benefits are explored. This collection should prove helpful to health care policy specialists, managers and researchers interested in gaining a feel for the real-world application of cost-focused health services research.

Controlling costs in health care is rarely something that can be tackled in isolation. Cost control invariably interacts with issues of quality and health care access. Thus, this diverse collection of papers is concerned not just with costs but more importantly with value. Both macro and micro concerns are covered. At the macro level, health care reforms (and especially the 'marketisation' of health care systems) receive some attention. Papers explore how policy prescriptions get translated and modified during implementation, and assess how these prescriptions impact on both the incentive context and subsequent patterns of service delivery. Resource allocation within bureaucratic health systems continues to pose problems and these too are analysed with new solutions being proposed. At the micro level, a number of contributors wrestle with the difficulties of carrying out the economic evaluation of new drugs and technologies. In each case, the wider theoretical and practical implications of balancing costs and benefits are explored. This collection should prove helpful to health care policy specialists, managers and researchers interested in gaining a feel for the real-world application of cost-focused health services research.